NAD+ Precursor Chews for a Dog Whose Energy Dropped After Turning 8
Medically reviewed by Tamara Shearer, DVM, MSTCVM, CCRP, CVPP, CVA, CHPV, CTPEP — For general education — not a substitute for veterinary care.
Wondering if NAD+ precursor chews help when a senior dog's energy dropped after age 8? Here's what evidence shows.
On this page
- Why Did My Dog’s Energy Drop Right Around Age 8?
- What Is NAD+, and Why Does a Precursor Chew Target It?
- Does the Research in Dogs Actually Back This Up?
- What About the Quercetin and Resveratrol Often Paired With It?
- How Do I Choose a Chew Without Falling for Marketing?
- Where Rehab and Comfort Fit Into the Bigger Picture
- The Short Version
Why Did My Dog’s Energy Drop Right Around Age 8?
A slower dog at 8 is common enough that owners often wave it off as simply getting older. Sometimes that is exactly what it is. But pain from early arthritis, dental disease, low thyroid function, anemia, or early organ changes can all present the same way: a dog who sleeps more, greets you with less enthusiasm, and cuts the walk short. As a hospice and palliative-care vet, I see this crossroads often, and my honest answer is that the first step is never a supplement. It is bloodwork, a hands-on exam, and an honest conversation about what has actually changed at home.
Once those causes are checked and either ruled out or being managed, NAD+ precursor chews are a fair thing to ask about. This guide walks through what they are, what the evidence currently says, and how to judge a product without overpromising what a chew can do.

What Is NAD+, and Why Does a Precursor Chew Target It?
NAD+ is a coenzyme that nearly every cell in the body needs to convert food into usable energy. According to the National Institutes of Health, Office of Dietary Supplements, all tissue converts absorbed niacin into NAD, and more than 400 enzymes rely on it, more than any other vitamin-derived coenzyme in the body. Nicotinamide riboside is one of the related forms the fact sheet describes, and it is the compound most senior-dog chews use as their NAD+ precursor.
The logic behind supplementing it is straightforward, even if the proof in dogs is still developing: cellular NAD+ levels are believed to decline somewhat with age, and a precursor gives cells more raw material to rebuild the pool. That is a mechanism, not a guarantee. A precursor chew supports normal cellular function; it does not reverse an underlying disease, and no reputable source frames it that way.
Does the Research in Dogs Actually Back This Up?
This is where I want to be direct with you rather than hopeful. A randomized, controlled trial published in Scientific Reports tested a senolytic paired with an NAD+ precursor in senior dogs and found improved owner-assessed cognitive function over the study period. That is a real, peer-reviewed signal, and it is more than most pet supplements can point to. It is also a single trial, on a specific combination product, over a defined window — not a blanket finding that any NAD+ chew works the same way, and not evidence of a longer life.
Separately, a subacute toxicity study on nicotinamide mononucleotide, a related NAD+ precursor, reported only mild changes in creatinine and uric acid at the doses tested, which the National Center for Biotechnology Information summary frames as reassuring for a safe oral dose range rather than proof of benefit. Safety data and efficacy data are two different questions, and it matters that you don’t collapse them into one.
Here is the plain version: the direction of the research is encouraging. It is not yet the kind of large, replicated body of evidence I’d want before calling anything definitive for your specific dog.
What About the Quercetin and Resveratrol Often Paired With It?
Many chews stack an NAD+ precursor with antioxidants like quercetin and resveratrol, and it is worth knowing what that pairing is and is not backed by right now. Quercetin is a flavonoid studied for antioxidant, immune, and cellular support properties, and current evidence for it is largely early-stage: one lab study noted that quercetin, along with related compounds like NAC and ascorbic acid, did not affect feeding behavior in the model organism tested, published in Pharmaceuticals. Resveratrol has a similarly mixed early picture; a Phytomedicine study found that embryonic exposure to one resveratrol derivative sped up development but shortened adult lifespan in the model tested, a reminder that dose and life stage matter and that in-vitro or invertebrate findings don’t transfer neatly to a middle-aged dog.
None of this means the ingredients are unsafe at typical supplement doses. It means the antioxidant story is still mostly a laboratory one, and I’d rather tell you that plainly than let a label imply more certainty than the science currently offers.

How Do I Choose a Chew Without Falling for Marketing?
A few concrete things to check before you buy anything:
- Look for the NASC Quality Seal. The National Animal Supplement Council requires member companies to pass an independent third-party facility audit, maintain a quality management system, and report adverse events, which is a meaningfully higher bar than an unaudited label claim.
- Confirm the label states a specific milligram dose per chew rather than a vague blend name — you want to know what your dog is actually getting, not just what it’s called.
- Ask your vet before starting, especially if your dog is on other medications or has kidney or liver disease, since dosing decisions should be individualized to your dog’s health status.
- Give a trial a real window, generally six to eight weeks, and track something concrete — stairs, walk length, willingness to play — rather than relying on a general impression after a few days.
Where Rehab and Comfort Fit Into the Bigger Picture
If your dog’s energy drop turns out to be pain-related, which is common at this age, a chew alone will not carry the weight. In my own practice, weight management, gentle rehabilitation exercise, and sometimes acupuncture do more for day-to-day comfort than any single supplement, and they work well alongside an NAD+ precursor chew rather than instead of one. The goal at 8 years old is rarely to chase a number on a lab report. It’s to keep your dog’s daily life comfortable, mobile, and genuinely enjoyable for as long as that’s realistically possible.
The Short Version
Start with your vet, not the supplement aisle. If bloodwork and an exam come back reassuring, an NASC-sealed NAD+ precursor chew is a low-risk, evidence-informed option to layer on top of good pain management and activity — framed as support for normal aging, not a cure and not a lifespan promise.
Frequently asked questions
Is a drop in energy at age 8 always aging, or could it be something else?
It can be ordinary aging, but pain, thyroid changes, anemia, heart or organ disease, and dental discomfort can all look identical from the outside. Bloodwork and a physical exam are how we tell these apart, not guesswork at home.
How long before I'd notice a difference from an NAD+ precursor chew?
Most owners who report a change describe it over several weeks, not days. Give it a defined trial window, keep a simple log of walks and play, and reassess with your vet rather than stopping or judging too early.
Can NAD+ precursor chews replace pain management or a mobility plan?
No. If discomfort is driving the energy drop, a chew is not a treatment for pain. Rehab, acupuncture, weight management, and appropriate pain control belong at the center of the plan; a supplement sits alongside it, not in place of it.
Sources
- Niacin - Health Professional Fact Sheet — National Institutes of Health, Office of Dietary Supplements
- National Animal Supplement Council — National Animal Supplement Council
- A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD+ precursor combination — Scientific Reports
- Effects of quercetin and related compounds on feeding behavior — Pharmaceuticals
- Embryonic exposure and lifespan effects of resveratrol derivatives — Phytomedicine
- Subacute Toxicity Study of Nicotinamide Mononucleotide via Oral Administration — National Center for Biotechnology Information